BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.3510
-0.0280 (-7.39%)
At close: May 29, 2026

BioCorRx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3.43-3.44-5.11-3.77-4.37-5.21
Depreciation & Amortization
0.070.080.10.20.140.17
Other Amortization
0.480.531.10.640.490.48
Asset Writedown & Restructuring Costs
0.01--0.05-0.14
Stock-Based Compensation
0.550.591.220.280.350.21
Other Operating Activities
0.390.450.070.030.76-0.03
Change in Accounts Receivable
-0.22-0.2500.03-0.03-0
Change in Inventory
-0.01-0.01----
Change in Accounts Payable
0.520.291.440.80.840.7
Change in Unearned Revenue
-0.06-0.060.05-0.03-0.03-0.13
Change in Other Net Operating Assets
-0.36-0.480.03-0.09-0.190.14
Operating Cash Flow
-2.04-2.3-1.1-1.85-2.04-3.54
Capital Expenditures
------0
Sale (Purchase) of Intangibles
------0.05
Investing Cash Flow
------0.05
Short-Term Debt Issued
-1.151.130.970.780.7
Long-Term Debt Issued
-----0.13
Total Debt Issued
0.61.151.130.970.780.83
Short-Term Debt Repaid
--0.68-0.01-0.04--
Long-Term Debt Repaid
--0-0-0-0-
Total Debt Repaid
-0.75-0.68-0.01-0.04-0-
Net Debt Issued (Repaid)
-0.150.471.120.930.770.83
Issuance of Common Stock
2.381.88-0.921.252.25
Financing Cash Flow
2.232.351.121.852.023.08
Net Cash Flow
0.190.050.02-0-0.02-0.51
Free Cash Flow
-2.04-2.3-1.1-1.85-2.04-3.54
Free Cash Flow Margin
-232.83%-288.28%-14302.07%-2078.60%-954.81%-7332.77%
Free Cash Flow Per Share
-0.10-0.12-0.10-0.22-0.28-0.55
Cash Interest Paid
0.520.520.010.02--
Levered Free Cash Flow
-7.02-2.27-0.72-0.88-2.01-2.06
Unlevered Free Cash Flow
-7.02-2.27-0.87-0.97-1.83-2.18
Change in Working Capital
-0.12-0.511.520.710.580.7